世界贸易中心的老年响应者中的多药性和脆弱性
Chinmayi Venkatram1, Fred Ko2,3, Ghalib Bello4
1Department of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
PloS one
|December 4, 2025
概括
多药和增加跌倒风险的药物使用在老年世界贸易中心 (WTC) 应急人员中很常见. 优化药物管理对于这个暴露于环境危害的人群健康老龄化至关重要.
科学领域:
- 环境健康 环境健康
- 老年学是一门学科.
- 临床药房 临床药房
背景情况:
- 世界贸易中心 (WTC) 应急人员在9/11恢复工作期间面临环境危险.
- 这些暴露可能会加速老龄化,并增加这个人群的脆弱性.
- 了解药物风险对于WTC应急人员的长期健康至关重要.
研究的目的:
- 检查多药和衰老WTC响应者的脆弱性之间的关系.
- 为了确定与多药和降低风险增加药物 (FRID) 使用相关的因素.
- 在这个群体中,为减轻与药物相关风险的策略提供信息.
主要方法:
- 该研究包括来自2017-2019年WTC健康计划数据的50岁以上WTC受访者.
- 使用WTC特定的临床脆弱性指数评估的脆弱性.
- 多变量逻辑回归分析了与多药 (≥5种药物) 和FRID使用的关联,并对共变量进行调整.
主要成果:
- 在6,966名WTC受访者中,55%使用多药;7.6%使用FRID.
- 虚弱与多药 (OR 1.15) 和FRID使用 (OR 1.11) 独立相关.
- 老年,肥胖,保护性服务工作,GERD,阻塞性呼吸道疾病和上呼吸道疾病与更高的多药制药几率有关. 女性的性行为,吸烟,焦虑,抑郁和PTSD与更高的FRID使用率有关.
结论:
- 在老年WTC响应者中观察到多药和FRID使用的高患病率.
- 脆弱性与多药和FRID使用显著相关.
- 优化药物管理对于促进WTC响应者健康老龄化至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221


